Shares of Apellis Pharmaceuticals, Inc. APLS were up 7.3% on Thursday after the company announced that it has entered into a research collaboration with Cambridge, MA-based Beam Therapeutics Inc. BEAM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback